Evidence map›Paper›PMID 38001736›Full record

ArticleCancers2023

An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.

Ken Kudura, Nando Ritz, Arnoud J Templeton, Tim Kutzker, Martin H K Hoffmann, Kwadwo Antwi, Daniel R Zwahlen, Michael C Kreissl, Robert Foerster

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Ken KuduraDepartment of Nuclear Medicine, Sankt Clara Hospital, 4058 Basel, Switzerland.
Nando RitzFaculty of Medicine, University of Basel, 4001 Basel, Switzerland.
Arnoud J TempletonSankt Clara Research, 4002 Basel, Switzerland.ORCID 0000-0002-0847-7087
Tim KutzkerFaculty of Applied Statistics, Humboldt University, 10117 Berlin, Germany.
Martin H K HoffmannDepartment of Nuclear Medicine, Sankt Clara Hospital, 4058 Basel, Switzerland.
Kwadwo AntwiDepartment of Nuclear Medicine, Sankt Clara Hospital, 4058 Basel, Switzerland.
Daniel R ZwahlenDepartment of Radiooncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.ORCID 0000-0003-4359-7735
Michael C KreisslDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.ORCID 0000-0001-5905-6015
Robert FoersterDepartment of Radiooncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.ORCID 0000-0002-7664-9207
St. Claraspital · CHKantonsspital Winterthur · CHUniversity of Basel · CHHumboldt-Universität zu Berlin · DEUniversity Hospital Magdeburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerclinical benefitFDG-PET/CTgeneralized additive modelPET/CTprediction model

Identifiers

PMID38001736
PMCPMC10670812
OpenAlexW4388830903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.